Biosynth Carbosynth Acquires Pepscan to Expand GMP Manufacturing Capabilities.

MANews-(C)2009-2022

Switzerland-based life sciences products and services provider Biosynth Carbosynth has acquired Netherlands-based peptide-based products and services provider Pepscan, to expand peptide offering and GMP manufacturing capabilities, the company said.

Terms of the transaction were not disclosed.

Biosynth's ability to deliver chemical manufacturing services is now matched in peptides, with Pepscan's expertise in both lead discovery and optimisation and GMP production combining with the capabilities of vivitide, the US peptide specialists.

The two companies will form Biosynth's new Peptide division, with broad capabilities and offering to the pharma and biotech, diagnostics and cosmetics industries, and their academic counterparts.

The addition of Pepscan...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT